Published online December 29, 2008
PEDIATRICS Vol. 123 No. 1 January 2009, pp. 214-222 (doi:10.1542/peds.2008-0522)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inge, T. H.
Right arrow Articles by Dolan, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inge, T. H.
Right arrow Articles by Dolan, L. M.
Related Collections
Right arrow Surgery
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Reversal of Type 2 Diabetes Mellitus and Improvements in Cardiovascular Risk Factors After Surgical Weight Loss in Adolescents

Thomas H. Inge, MD, PhDa, Go Miyano, MDa, Judy Bean, PhDb, Michael Helmrath, MDc, Anita Courcoulas, MDd, Carroll M. Harmon, MDe, Mike K. Chen, MDf, Kimberly Wilson, MDa, Stephen R. Daniels, MDg, Victor F. Garcia, MDa, Mary L. Brandt, MDh and Lawrence M. Dolan, MDi

Divisions of a Pediatric Surgery
i Endocrinology
b Center for Epidemiology and Biostatistics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
c Departments of Surgery and Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina
d Division of Minimally Invasive Bariatric and General Surgery, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
e Department of Surgery and Division of Pediatric Surgery, University of Alabama at Birmingham, Birmingham, Alabama
f Division of Pediatric Surgery, University of Florida, Gainesville, Florida
g Department of Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado
h Division of Pediatric Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas

OBJECTIVES. Type 2 diabetes mellitus is associated with obesity, dyslipidemia, and hypertension, all well-known risk factors for cardiovascular disease. Surgical weight loss has resulted in a marked reduction of these risk factors in adults. We hypothesized that gastric bypass would improve parameters of metabolic dysfunction and cardiovascular risk in adolescents with type 2 diabetes mellitus.

PATIENTS AND METHODS. Eleven adolescents who underwent Roux-en-Y gastric bypass at 5 centers were included. Anthropometric, hemodynamic, and biochemical measures and surgical complications were analyzed. Similar measures from 67 adolescents with type 2 diabetes mellitus who were treated medically for 1 year were also analyzed.

RESULTS. Adolescents who underwent Roux-en-Y gastric bypass were extremely obese (mean BMI of 50 ± 5.9 kg/m2) with numerous cardiovascular risk factors. After surgery there was evidence of remission of type 2 diabetes mellitus in all but 1 patient. Significant improvements in BMI (–34%), fasting blood glucose (–41%), fasting insulin concentrations (–81%), hemoglobin A1c levels (7.3%–5.6%), and insulin sensitivity were also seen. There were significant improvements in serum lipid levels and blood pressure. In comparison, adolescents with type 2 diabetes mellitus who were followed during 1 year of medical treatment demonstrated stable body weight (baseline BMI: 35 ± 7.3 kg/m2; 1-year BMI: 34.9 ± 7.2 kg/m2) and no significant change in blood pressure or in diabetic medication use. Medically managed patients had significantly improved hemoglobin A1c levels over 1 year (baseline: 7.85% ± 2.3%; 1 year: 7.1% ± 2%).

CONCLUSIONS. Extremely obese diabetic adolescents experience significant weight loss and remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass. Improvements in insulin resistance, β-cell function, and cardiovascular risk factors support Roux-en-Y gastric bypass as an intervention that improves the health of these adolescents. Although the long-term efficacy of Roux-en-Y gastric bypass is not known, these findings suggest that Roux-en-Y gastric bypass is an effective option for the treatment of extremely obese adolescents with type 2 diabetes mellitus.


Key Words: adolescent • type 2 diabetes mellitus • weight loss surgery • gastric bypass

Abbreviations: T2DM—type 2 diabetes mellitus • RYGB—Roux-en-Y gastric bypass • HOMA—homeostasis model assessment • HOMA2-IR—index of insulin resistance • HOMA2%S—index of insulin sensitivity • HOMA2-%B—index of β-cell function


Accepted Apr 23, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
CardioPulse Articles
Eur. Heart J., August 2, 2009; 30(16): 1927 - 1935.
[Full Text] [PDF]

eLetters:

Read all eLetters

Gastric Bypass for obesity in children: Too much – Too Late!
Diana L. Farmer, MD
Pediatrics Online, 4 Feb 2009 [Full text]